Co-expression network analysis identified novel potential Signature Genes Associated with human left ventricle cardiomyopathies arises from different etiologies
Abstract Background: Heart disease is global pandemic and causes huge healthcare burden to society. However, it is still illusive that the whole transcription disorder pattern of cardiomyopathies arises from different etiologies. The Weighted Gene Co-Expression Network Analysis (WGCNA) was applied to construct and screen functional gene that be significantly related to different cardiomyopathies pathological feature. Through co-expression and protein-protein interaction (PPI) networks enrichment analysis, the hub genes and key pathways were screened, which were correlated to cardiomyopathy traits. To discover the novel disease signature genes, cardiovascular disease bioportal database and were employed to blast and validate, which contained independently investigations of clinical cardiomyopathies cases. Results: The potential disease signature genes were identified and assorted into three common axes shared among five subtype of cardiomyopathies. Four genes (MDM4, CFLAR, RPS6KB1, PKD1L2) were shared by ischemic and ischemic cardiomyopathy group. The secondary axe contained eight signature genes (MAPK1, MAPK11, MAPK14, LMNA, RAC1, PECAM1, XIAP, CREB1) and was overlapped by Ischemic Cardiomyopathy, Post. Partum Cardiomyopathy, Familiar Cardiomyopathy and Idiopathic Cardiomyopathy. The third axe consisted of two common signature genes (TFAM, RHEB) that shared among the subgroups of Viral Cardiomyopathy, Post. Partum Cardiomyopathy, Familiar Cardiomyopathy and Idiopathic Cardiomyopathy. The majority of disorder functions and pathways were enriched in metabolic processes and pathways of MAPK signaling, protein processing in endoplasmic reticulum, regulation of actin cytoskeleton. Conclusion: These results strongly suggest that expression disorder of signature genes contribute to the cardiac dysregulation and functional relapse into cardiomyopathies. Taken together, these novel signature genes could be utilized as potential diagnostic biomarkers or therapy targets. It will be benefit the cardiomyopathy precise clinical diagnostics with better outcome. In summary, this study will attract great interest of clinical research scientists as well as medical scientists that work on heart diseases.